10.77021.21% ( -2.900 )
Closed: Nov 16, 16:00:00 (EDT)Shareholders
All Shareholders
Shareholder Type
- Public and others32.45%
- VC/PE firms25.25%
- Public companies22.96%
- Institutions17.42%
- Individuals & Insiders1.92%
Major Shareholders
| Shareholder | |||||
|---|---|---|---|---|---|
Eli Lilly and Company | 20.36% | 5.48M | -- | +5.48M | |
SV Health Investors, LLC | 14.77% | 3.98M | -- | +3.98M | |
Johnson & Johnson Innovation - JJDC, Inc. | 5.48% | 1.48M | -- | +1.48M | |
Alexandria Venture Investments, LLC | 5.00% | 1.35M | -- | +1.35M | |
Pfizer Venture Investments LLC | 4.70% | 1.27M | -- | +1.27M | |
Janus Henderson Group Ltd. | 4.67% | 1.26M | -- | +1.26M | |
Delos Capital | 4.27% | 1.15M | -- | +1.15M | |
Polaris Growth Management, L.L.C. | 3.78% | 1.02M | -- | +1.02M | |
Pfizer Inc. | 2.60% | 700.00K | -- | +700.00K | |
Carol GallagherLead Independent Director | 0.93% | 251.47K | -- | +251.47K | |
Laura BernerChief Operating Officer | 0.63% | 168.57K | -- | +168.57K | |
Joel MarcusIndependent Director | 0.16% | 41.87K | -- | +41.87K | |
K. HirthIndependent Director | 0.14% | 38.20K | -- | +38.20K | |
Ali ZarrinChief Scientific Officer & Executive Director of Drug Discovery | 0.07% | 18.11K | -- | +18.11K | |
Transce3nd, LLC | <0.01% | 100.00 | -- | +100.00 | |
Travis CoyIndependent Director | 0.00% | 0.00 | -- | +0 | |
Marion ErwinChairman & CEO | 0.00% | 0.00 | -- | +0 |
